5-碘-吡啶-2-羧酸酰胺 | 41960-46-7

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-碘-吡啶-2-羧酸酰胺
• 英文名称: 5-Iodpicolinamid
• 英文别名: 5-iodo-pyridine-2-carboxylic acid amide；5-Iodopicolinamide；5-iodopyridine-2-carboxamide
• CAS: 41960-46-7
• 化学式: C₆H₅IN₂O
• 分子量: 248.023
• InChiKey: JYINBVIDWNJXNC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  56
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  、 5-碘-吡啶-2-羧酸酰胺 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 sodium carbonate 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 1.5h， 生成 5-(5-(1-oxo-1,3-dihydroisobenzofuran-5-yl)thiophen-2-yl)picolinamide
  参考文献：
  名称：

  Diarylthiophenes as inhibitors of the pore-forming protein perforin

  摘要：

  Evolution from a furan-containing high-throughput screen (HTS) hit (1) resulted in isobenzofuran-1(3H)-one (2) as a potent inhibitor of the function of both isolated perforin protein and perforin delivered in situ by intact KHYG-1 NK cells. In the current study, structure-activity relationship (SAR) development towards a novel series of diarylthiophene analogues has continued through the use of substituted-benzene and -pyridyl moieties as bioisosteres for 2-thioxoimidazolidin-4-one (A) on a thiophene (B) -isobenzofuranone (C) scaffold. The resulting compounds were tested for their ability to inhibit perforin lytic activity in vitro. Carboxamide (23) shows a 4-fold increase over (2) in lytic activity against isolated perforin and provides good rationale for continued development within this class. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license.

  DOI：

  10.1016/j.bmcl.2015.12.003
• 作为产物：
  描述：

  5-溴吡啶甲酰胺 在 copper(l) iodide 、 (1R,2R)-(-)-N,N'-二甲基-1,2-环己二胺 、 sodium iodide 作用下， 以 1,4-二氧六环 为溶剂， 反应 24.0h， 生成 5-碘-吡啶-2-羧酸酰胺
  参考文献：
  名称：

  Diarylthiophenes as inhibitors of the pore-forming protein perforin

  摘要：

  Evolution from a furan-containing high-throughput screen (HTS) hit (1) resulted in isobenzofuran-1(3H)-one (2) as a potent inhibitor of the function of both isolated perforin protein and perforin delivered in situ by intact KHYG-1 NK cells. In the current study, structure-activity relationship (SAR) development towards a novel series of diarylthiophene analogues has continued through the use of substituted-benzene and -pyridyl moieties as bioisosteres for 2-thioxoimidazolidin-4-one (A) on a thiophene (B) -isobenzofuranone (C) scaffold. The resulting compounds were tested for their ability to inhibit perforin lytic activity in vitro. Carboxamide (23) shows a 4-fold increase over (2) in lytic activity against isolated perforin and provides good rationale for continued development within this class. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license.

  DOI：

  10.1016/j.bmcl.2015.12.003

文献信息

• Substituted Pyrrolidine-2-Carboxamides
  申请人：Ding Qingjie

  公开号：US20100075948A1

  公开（公告）日：2010-03-25

  There are provided compounds of the formula wherein X, Y, R 1 , R 2 , R 3 , R 3 , R 4 , R 5 , R 6 and R 7 are as described herein and enantiomers and pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.

  提供了以下式的化合物 其中X、Y、R1、R2、R3、R3、R4、R5、R6和R7如本文所述，以及其对映体和药用可接受的盐和酯。这些化合物可用作抗癌药物。
• Novel amides useful for treating pain
  申请人：Zheng Zhu Guo

  公开号：US20050080095A1

  公开（公告）日：2005-04-14

  The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R 6 , R 7 and R 8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.

  本发明涉及式(I-VII)的化合物或其药用可接受的盐或前药，其中A、L、R6、R7和R8在此有所定义。本发明还涉及使用这些化合物治疗疼痛的方法以及包含这些化合物的药物组合物。
• [EN] IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS<br/>[FR] DÉRIVÉS D'IMIDAZO [1,5-A] PYRAZINE EN TANT QU'INHIBITEURS DE PI3KDELTA
  申请人：BEIGENE LTD

  公开号：WO2018103688A1

  公开（公告）日：2018-06-14

  Disclosed is a compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating PI3Kδ related disorders or diseases by using the compound disclosed herein.

  揭示的是化合物的化学式（I），或其立体异构体，或其药学上可接受的盐，以及包含其的药物组合物。还公开了利用此处披露的化合物治疗PI3Kδ相关疾病或疾病的方法。
• [EN] SULFONAMIDE DERIVATIVES<br/>[FR] DERIVES DE SULFAMIDE
  申请人：CELLTECH R&D LTD

  公开号：WO2003087071A1

  公开（公告）日：2003-10-23

  Sulfonamide derivatives of formula (1) are described wherein X is an O or S atom; Y is an 0 or S atom; A is a group -S02NR1R2; m is zero or the integer 1; n is zero or the integer 1; provided that at least one but not both of m and n are the integer 1; R3 is a hydrogen atom or an alkyl or cycloalkyl group; and the salts, solvates, hydrates, tautomers, isomers, N-oxides thereof. The compounds are potent inhibitors of IMPDH and are of use as immunosuppressants, anti-cancer agents, anti-inflammatory agents, antipsoriatic and anti-viral agents.

  描述了式（1）的磺酰胺衍生物，其中X是O或S原子；Y是0或S原子；A是-S02NR1R2基团；m为零或整数1；n为零或整数1；前提是m和n中至少有一个但不是两个都是整数1；R3是氢原子或烷基或环烷基；以及其盐，溶剂合物，水合物，互变异构体，N-氧化物。这些化合物是IMPDH的有效抑制剂，并可用作免疫抑制剂，抗癌剂，抗炎剂，抗银屑病和抗病毒剂。
• MRNA-BASED GENE EXPRESSION FOR PERSONALIZING PATIENT CANCER THERAPY WITH AN MDM2 ANTAGONIST
  申请人：Hoffmann-La Roche Inc.

  公开号：US20150211073A1

  公开（公告）日：2015-07-30

  Use of at least an MDM2 gene panel, preferably a four gene MDM2 gene panel, as a biomarker for predicting the response to a MDM2 antagonist.

  至少使用一个MDM2基因面板，最好是一个四基因MDM2基因面板，作为预测对MDM2拮抗剂反应的生物标志物。